Table 1 Treatments in juvenile idiopathic arthritis (JIA) patients with abnormal and normal cervical cytology
From: Lower genital tract infections in young female juvenile idiopathic arthritis patients
Variables | Abnormal cervical cytology (n = 8) | Normal cervical cytology (n = 25) | p |
|---|---|---|---|
Treatment | |||
Prednisone, current use | 2 (25) | 4 (16) | 0.616 |
Current dose, mg/day | 6.3 (5–7.5) | 5 (5–9) | 0.800 |
Cumulative dose, grams | 2 (0–137.7) | 10 (0–61.2) | 0.785 |
Methotrexate, current use | 1 (12) | 11 (44) | 0.206 |
Current dose, mg/week | 15 (15–15) | 20 (10–25) | 0.383 |
Cumulative dose, grams | 1.7 (0–16.7) | 6.3 (0.3–20.5) | 0.034 |
Biologic agents, current or previous use | 3 (37) | 16 (64) | 0.238 |
Etanercept | 1 (12) | 6 (24) | 0.652 |
Adalimumab | 0 (0) | 2 (8) | 1.000 |
Golimumab | 0 (0) | 1 (4) | 1.000 |
Certolizumab | 0 (0) | 1 (4) | 1.000 |
Infliximab | 1 (12) | 0 (0) | 0.242 |
Tocilizumab | 1 (12) | 4 (16) | 1.000 |
Abatacept | 0 (0) | 2 (8) | 1.000 |